Kumho HT, Inc.
Records under this name other than the patents Kumho HT, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 5 of 5 · Back to Kumho HT, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,622,560 | Monoclonal antibody specific for CD43 epitope Term ended Term ended May 20, 2026 · USPTO record | Term ended | Term ended May 20, 2026 | USPTO record |
| US 8,753,636 | Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof Term ended Term ended Dec 20, 2025 · USPTO record | Term ended | Term ended Dec 20, 2025 | USPTO record |
| US 9,746,474 | Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof Lapsed on the fee record Ended Aug 29, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 29, 2025 | USPTO record |
| US 8,426,555 | Acute leukemia and lymphoblastic lymphona-specific CD43 epitope Lapsed on the fee record Ended Apr 23, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 23, 2025 | USPTO record |
| US 8,404,812 | Epitope of CD66C specific to lung adenocarcinoma and antibody recognizing the same Lapsed on the fee record Ended Mar 26, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 26, 2025 | USPTO record |